HPGC Renmintongtai Pharmaceutical Corp (600829) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.063x

Based on the latest financial reports, HPGC Renmintongtai Pharmaceutical Corp (600829) has a cash flow conversion efficiency ratio of -0.063x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-187.38 Million ≈ $-27.42 Million USD) by net assets (CN¥2.99 Billion ≈ $437.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HPGC Renmintongtai Pharmaceutical Corp defensive interval ratio to measure how many days the company can operate on defensive assets alone.

HPGC Renmintongtai Pharmaceutical Corp - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how HPGC Renmintongtai Pharmaceutical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

HPGC Renmintongtai Pharmaceutical Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HPGC Renmintongtai Pharmaceutical Corp ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Sichuan Mingxing Electric Power Co Ltd
SHG:600101
0.044x
Synektik S.A.
WAR:SNT
0.376x
Cogent Communications Group Inc
NASDAQ:CCOI
-0.079x
CEWE Stiftung & Co. KGaA
XETRA:CWC
-0.010x
Admie Holding S.A
AT:ADMIE
0.048x
Ardmore Shpng
NYSE:ASC
0.041x
Manitou BF S.A.
PA:MTU
0.154x
Fidus Investment Corp
NASDAQ:FDUS
0.018x

Annual Cash Flow Conversion Efficiency for HPGC Renmintongtai Pharmaceutical Corp (1998–2025)

The table below shows the annual cash flow conversion efficiency of HPGC Renmintongtai Pharmaceutical Corp from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see HPGC Renmintongtai Pharmaceutical Corp market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥3.01 Billion
≈ $441.19 Million
CN¥299.98 Million
≈ $43.90 Million
0.099x +148.33%
2024-12-31 CN¥2.88 Billion
≈ $421.60 Million
CN¥115.44 Million
≈ $16.89 Million
0.040x -66.89%
2023-12-31 CN¥2.75 Billion
≈ $402.61 Million
CN¥332.99 Million
≈ $48.73 Million
0.121x -3.02%
2022-12-31 CN¥2.46 Billion
≈ $360.36 Million
CN¥307.33 Million
≈ $44.97 Million
0.125x +217.79%
2021-12-31 CN¥2.20 Billion
≈ $321.82 Million
CN¥-233.00 Million
≈ $-34.10 Million
-0.106x -2188.91%
2020-12-31 CN¥1.99 Billion
≈ $291.54 Million
CN¥-9.22 Million
≈ $-1.35 Million
-0.005x +97.92%
2019-12-31 CN¥1.85 Billion
≈ $270.31 Million
CN¥-411.60 Million
≈ $-60.23 Million
-0.223x -196.07%
2018-12-31 CN¥1.58 Billion
≈ $231.19 Million
CN¥366.45 Million
≈ $53.62 Million
0.232x +168.84%
2017-12-31 CN¥1.61 Billion
≈ $235.89 Million
CN¥139.07 Million
≈ $20.35 Million
0.086x +208.97%
2016-12-31 CN¥1.65 Billion
≈ $241.12 Million
CN¥46.01 Million
≈ $6.73 Million
0.028x -88.10%
2015-12-31 CN¥1.42 Billion
≈ $208.27 Million
CN¥333.99 Million
≈ $48.87 Million
0.235x +28.70%
2014-12-31 CN¥2.15 Billion
≈ $315.05 Million
CN¥392.58 Million
≈ $57.45 Million
0.182x +360.00%
2013-12-31 CN¥2.26 Billion
≈ $330.33 Million
CN¥-158.31 Million
≈ $-23.17 Million
-0.070x -172.98%
2012-12-31 CN¥2.31 Billion
≈ $337.41 Million
CN¥221.57 Million
≈ $32.42 Million
0.096x +271.75%
2011-12-31 CN¥1.94 Billion
≈ $283.25 Million
CN¥-108.30 Million
≈ $-15.85 Million
-0.056x -159.69%
2010-12-31 CN¥1.74 Billion
≈ $254.43 Million
CN¥162.99 Million
≈ $23.85 Million
0.094x -65.32%
2009-12-31 CN¥1.66 Billion
≈ $242.41 Million
CN¥447.82 Million
≈ $65.53 Million
0.270x +776.00%
2008-12-31 CN¥1.65 Billion
≈ $241.27 Million
CN¥-65.93 Million
≈ $-9.65 Million
-0.040x -129.42%
2007-12-31 CN¥1.41 Billion
≈ $205.71 Million
CN¥191.10 Million
≈ $27.96 Million
0.136x -22.95%
2006-12-31 CN¥1.08 Billion
≈ $158.53 Million
CN¥191.13 Million
≈ $27.97 Million
0.176x -49.94%
2005-12-31 CN¥888.23 Million
≈ $129.98 Million
CN¥313.04 Million
≈ $45.81 Million
0.352x +504.14%
2004-12-31 CN¥1.04 Billion
≈ $152.24 Million
CN¥60.69 Million
≈ $8.88 Million
0.058x -54.38%
2003-12-31 CN¥560.39 Million
≈ $82.00 Million
CN¥71.65 Million
≈ $10.48 Million
0.128x -47.23%
2002-12-31 CN¥526.17 Million
≈ $77.00 Million
CN¥127.49 Million
≈ $18.66 Million
0.242x +720.86%
2001-12-31 CN¥501.11 Million
≈ $73.33 Million
CN¥14.79 Million
≈ $2.16 Million
0.030x -77.75%
2000-12-31 CN¥466.36 Million
≈ $68.24 Million
CN¥61.85 Million
≈ $9.05 Million
0.133x -3.81%
1999-12-31 CN¥422.13 Million
≈ $61.77 Million
CN¥58.21 Million
≈ $8.52 Million
0.138x +44.85%
1998-12-31 CN¥430.69 Million
≈ $63.02 Million
CN¥41.00 Million
≈ $6.00 Million
0.095x --

About HPGC Renmintongtai Pharmaceutical Corp

SHG:600829 China Drug Manufacturers - Specialty & Generic
Market Cap
$696.67 Million
CN¥4.76 Billion CNY
Market Cap Rank
#10747 Global
#2993 in China
Share Price
CN¥8.21
Change (1 day)
-0.97%
52-Week Range
CN¥7.22 - CN¥17.72
All Time High
CN¥17.72
About

HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese and Western patent medicines, Chinese herbal medicines and slices, chemical preparations, antibiotics, biological products, biochemical drugs, medical devices, and health products, as well as tonic health, daily necessities, and cosm… Read more